Dynamic contrast-enhanced magnetic resonance imaging in the early evaluation of anti-angiogenic therapy in metastatic renal cell carcinoma.

@article{Panebianco2013DynamicCM,
  title={Dynamic contrast-enhanced magnetic resonance imaging in the early evaluation of anti-angiogenic therapy in metastatic renal cell carcinoma.},
  author={Valeria Panebianco and Roberto Iacovelli and Flavio Barchetti and Amelia Altavilla and Valerio Forte and Alessandro Sciarra and Enrico Cortesi and Carlo Catalano},
  journal={Anticancer research},
  year={2013},
  volume={33 12},
  pages={5663-6}
}
AIM To evaluate the efficacy of dynamic contrast-enhanced magnetic resonance (DCE-MR) in the response to anti-angiogenic-targeted agents in patients with metastatic renal cell cancer (mRCC). PATIENTS AND METHODS Twenty-eight consecutive patients with sub-diaphragmatic metastases from mRCC were included in the protocol after signed informed consent. Baseline characteristics were collected and patients were first evaluated with a baseline computed tomography (CT) and DCE-MR, subsequently with a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

PET/MRI in Oncology

Springer International Publishing • 2018
View 20 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…